Bank of New York Mellon’s Gilead Sciences GILD Stock Holding History

Bank of New York Mellon’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Hold	13,800	–	–	﹤0.01%	3027
2026 Q1	$1.92M	Sell	13,800 -17,700	-56%	-$2.48M	﹤0.01%	2830
2025 Q4	$3.87M	Sell	31,500 -10,000	-24%	-$1.22M	﹤0.01%	2461
2025 Q3	$4.61M	Sell	41,500 -42,500	-51%	-$4.83M	﹤0.01%	2375
2025 Q2	$9.31M	Hold	84,000	–	–	﹤0.01%	1943
2025 Q1	$9.41M	Sell	84,000 -9,000	-10%	-$929K	﹤0.01%	1883
2024 Q4	$8.59M	Buy	+93,000	New	+$8.37M	﹤0.01%	2000

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of New York Mellon's GILD Position: Q2 2026 in Review

Bank of New York Mellon increased its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, buying an estimated $27.8M and bringing the position to 15,263,929 shares worth $1.93B. The position accounts for 0.32% of the portfolio, ranked #52.

Bank of New York Mellon first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.29B in Q2 2015. 1,755 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Bank of New York Mellon held 15,263,929 shares of Gilead Sciences worth $1.93B as of Q2 2026.
Bank of New York Mellon bought 210,778 Gilead Sciences shares in Q2 2026, an estimated $27.8M.
Gilead Sciences made up 0.32% of Bank of New York Mellon's portfolio in Q2 2026, its #52 holding.
Bank of New York Mellon first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
Bank of New York Mellon's Gilead Sciences position peaked at $3.29B in Q2 2015.
1,755 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.